GAMMA Investing LLC cut its holdings in shares of Dolby Laboratories (NYSE:DLB – Free Report) by 15.0% during the second quarter, HoldingsChannel.com reports. The fund owned 1,097 shares of the electronics maker’s stock after selling 194 shares during the quarter. GAMMA Investing LLC’s holdings in Dolby Laboratories were worth $81,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds have also modified their holdings of DLB. Securian Asset Management Inc. grew its position in Dolby Laboratories by 3.0% during the 1st quarter. Securian Asset Management Inc. now owns 4,648 shares of the electronics maker’s stock worth $373,000 after purchasing an additional 137 shares during the last quarter. MAI Capital Management grew its position in Dolby Laboratories by 87.1% during the 1st quarter. MAI Capital Management now owns 348 shares of the electronics maker’s stock worth $28,000 after purchasing an additional 162 shares during the last quarter. Net Worth Advisory Group grew its position in Dolby Laboratories by 5.2% during the 1st quarter. Net Worth Advisory Group now owns 3,591 shares of the electronics maker’s stock worth $288,000 after purchasing an additional 178 shares during the last quarter. US Bancorp DE grew its holdings in shares of Dolby Laboratories by 18.6% during the first quarter. US Bancorp DE now owns 1,444 shares of the electronics maker’s stock worth $116,000 after buying an additional 226 shares during the last quarter. Finally, Linden Thomas Advisory Services LLC grew its holdings in shares of Dolby Laboratories by 2.7% during the first quarter. Linden Thomas Advisory Services LLC now owns 8,635 shares of the electronics maker’s stock worth $693,000 after buying an additional 229 shares during the last quarter. 58.56% of the stock is currently owned by hedge funds and other institutional investors.
Insider Transactions at Dolby Laboratories
In related news, SVP Shriram Revankar sold 7,000 shares of Dolby Laboratories stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $74.92, for a total transaction of $524,440.00. Following the completion of the transaction, the senior vice president directly owned 70,435 shares of the company’s stock, valued at approximately $5,276,990.20. The trade was a 9.04% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CEO Kevin J. Yeaman sold 25,000 shares of the company’s stock in a transaction on Tuesday, September 16th. The shares were sold at an average price of $71.66, for a total value of $1,791,500.00. Following the completion of the sale, the chief executive officer directly owned 114,725 shares in the company, valued at $8,221,193.50. This trade represents a 17.89% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 99,366 shares of company stock worth $7,293,963. 38.39% of the stock is owned by insiders.
Dolby Laboratories Price Performance
Dolby Laboratories (NYSE:DLB – Get Free Report) last issued its earnings results on Thursday, July 31st. The electronics maker reported $0.78 EPS for the quarter, topping the consensus estimate of $0.72 by $0.06. The company had revenue of $315.55 million for the quarter, compared to analyst estimates of $305.23 million. Dolby Laboratories had a net margin of 19.62% and a return on equity of 11.52%. The business’s revenue was up 9.2% on a year-over-year basis. During the same period in the previous year, the firm earned $0.71 EPS. Dolby Laboratories has set its FY 2025 guidance at 3.880-4.030 EPS. Q4 2025 guidance at 0.610-0.760 EPS. On average, equities research analysts anticipate that Dolby Laboratories will post 2.94 EPS for the current fiscal year.
Dolby Laboratories Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Wednesday, August 20th. Investors of record on Tuesday, August 12th were issued a dividend of $0.33 per share. The ex-dividend date of this dividend was Tuesday, August 12th. This represents a $1.32 dividend on an annualized basis and a yield of 1.8%. Dolby Laboratories’s payout ratio is currently 48.35%.
Analyst Upgrades and Downgrades
DLB has been the topic of a number of research reports. Barrington Research reissued an “outperform” rating and set a $100.00 price target on shares of Dolby Laboratories in a report on Friday, September 12th. Wall Street Zen upgraded Dolby Laboratories from a “hold” rating to a “buy” rating in a research note on Saturday, August 30th. Tigress Financial lifted their price objective on shares of Dolby Laboratories from $112.00 to $114.00 and gave the company a “buy” rating in a research report on Friday, August 15th. Rosenblatt Securities reiterated a “buy” rating and issued a $95.00 price objective on shares of Dolby Laboratories in a research report on Friday, August 1st. Finally, Baird R W upgraded shares of Dolby Laboratories to a “hold” rating in a research report on Friday, September 5th. Three investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat, Dolby Laboratories has a consensus rating of “Moderate Buy” and a consensus target price of $95.75.
Read Our Latest Stock Report on DLB
About Dolby Laboratories
Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.
Recommended Stories
- Five stocks we like better than Dolby Laboratories
- What is the NASDAQ Stock Exchange?
- General Dynamics Hits New Highs: Why It Might Keep Climbing
- Options Trading – Understanding Strike Price
- Nike’s Turnaround: If the Shoe Fits, Buy It!
- Dividend Payout Ratio Calculator
- NVIDIA Breaks Out to New Highs: What Comes Next?
Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLB – Free Report).
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.